Disease-responsive drug delivery: The next generation of smart delivery devices

Current Drug Metabolism

Volumn 13, Issue 1, 2012, Pages 42-49

  Wanakule, Prinda ^a   Roy, Krishnendu ^a  

^a The University of Texas at Austin   (United States)

Author keywords

Drug delivery; Hydrogels; Microparticles; Nanoparticles; Stimuli responsive; Triggered release

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CISPLATIN; DOXORUBICIN; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; MACROGOL; MATRIX METALLOPROTEINASE; NANOCARRIER; PHOSPHOLIPID; POLYHISTIDINE;

ANTIBIOTIC RESISTANCE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIAL INFECTION; BINDING AFFINITY; BIOCOMPATIBILITY; CYTOTOXICITY; DIABETES CONTROL; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG UPTAKE; ELECTROSTIMULATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE DELIVERY SYSTEM; HUMAN; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; INFLAMMATORY DISEASE; INSULIN RELEASE; MAGNETIC FIELD; MYCOSIS; NEOPLASM; NONHUMAN; OSTEOMYELITIS; PATHOPHYSIOLOGY; PH; PHYSICAL CHEMISTRY; PROTEIN BINDING; PROTEIN INTERACTION; STIMULUS RESPONSE; TEMPERATURE; THERMAL STIMULATION; TUMOR MICROENVIRONMENT; ULTRASOUND; VIRUS INFECTION;

EID: 84857543458     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012798356880     Document Type: Article

References (104)

1. Bawa, P.; Pillay, V.; Choonara, Y.E.; du Toit, L.C. Stimuliresponsive polymers and their applications in drug delivery. Biomed. Mater., 2009, 4(2), 022001.
2. Caldorera-Moore, M.; Peppas, N.A. Micro-and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv. Drug Deliv. Rev., 2009, 61(15), 1391-1401.
3. Miyata, T.; Uragami, T.; Nakamae, K. Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev., 2002, 54(1), 79-98. (Pubitemid 34075315)
4. Caldorera-Moore, M.; Guimard, N.; Shi, L.; Roy, K. Designer nanoparticles: Incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin. Drug Deliv., 2010, 7(4), 479-495.
5. Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control Release, 2008, 126(3), 187-204.
6. Khare, A.R.; Peppas, N.A. Release behavior of bioactive agents from pH-sensitive hydrogels. J. Biomater. Sci. Polym. Ed., 1993, 4(3), 275-289.
7. Langer, R.; Peppas, N. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE Journal, 2003, 49(12), 2990-3006. (Pubitemid 38009884)
8. Löwik, D.W.P.M.; Leunissen, E.H.P.; van den Heuvel, M.; Hansen, M.B.; van Hest, J.C.M. Stimulus responsive peptide based materials. Chemical Society reviews, 2010, 39, 3394-3412.
9. Meng, F.; Hennink, W.E.; Zhong, Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials, 2009, 30(12), 2180-2198.
10. Onaca, O.; Enea, R.; Hughes, D.W.; Meier, W. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery. Macromolecular Bioscience, 2009, 9(2), 129-139.
11. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev., 2001, 53(3), 321-339. (Pubitemid 34024913)
12. Mudhakir, D.; Harashima, H. Learning from the viral journey: How to enter cells and how to overcome intracellular barriers to reach the nucleus. The AAPS Journal, 2009, 11(1), 65-77.
13. Pouton, C.W.; Wagstaff, K.M.; Roth, D.M.; Moseley, G.W.; Jans, D.A. Targeted delivery to the nucleus. Adv. Drug Deliv. Rev., 2007, 59(8), 698-717. (Pubitemid 47320817)
14. Putnam, D.; Gentry, C.A.; Pack, D.W.; Langer, R. Polymer-based gene delivery with low cytotoxicity by a unique balance of sidechain termini. PNAS, 2001, 98(3), 1200-1205. (Pubitemid 32121210)
15. Shaikh, R.P.; Pillay, V.; Choonara, Y.E.; du Toit, L.C.; Ndesendo, V.M.K.; Bawa, P.; Cooppan, S. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS Pharm.Sci.Tech., 2010, 11(1), 441-459.
16. Gallardo, D.; Skalsky, B.; Kleinebudde, P. Controlled release solid dosage forms using combinations of (meth)acrylate copolymers. Pharm. Dev. Technol., 2008, 13(5), 413-423.
17. Liu, F.; Basit, A.W. A paradigm shift in enteric coating: Achieving rapid release in the proximal small intestine of man. J. Control Release, 2010, 147(2), 242-245.
18. Boussif, O.; Lezoualc'h, F.; Zanta, M.A.; Mergny, M.D.; Scherman, D.; Demeneix, B.; Behr, J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. PNAS, 1995, 92(16), 7297-7301.
19. Benoit, D.S.W.; Henry, S.M.; Shubin, A.D.; Hoffman, A.S.; Stayton, P.S. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Molecular pharmaceutics, 2010, 7(2), 442-455.
20. Sawant, R.M.; Hurley, J.P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T.S.; Torchilin, V.P. "SMART" drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug. Chem., 2006, 17(4), 943-949. (Pubitemid 44162612)
21. Khare, A.R.; Peppas, N.A. Swelling/deswelling of anionic copolymer gels. Biomaterials, 1995, 16(7), 559-567.
22. Gao, W.; Chan, J.; Farokhzad, O.C. pH-responsive Nanoparticles for Drug Delivery. Molecular pharmaceutics, 2010, 7(6), 1913-1920.
23. You, J.-O.; Auguste, D.T. Feedback-regulated paclitaxel delivery based on poly(N,N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles. Biomaterials, 2008, 29(12), 1950-1957.
24. Johns, R.E.; El-Sayed, M.E.H.; Bulmus, V.; Cuschieri, J.; Maier, R.; Hoffman, A.S.; Stayton, P.S. Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic. J. Biomater. Sci. Polym. Ed., 2008, 19(10), 1333-1346.
25. Murthy, N.; Campbell, J.; Fausto, N.; Hoffman, A.S.; Stayton, P.S. Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. Bioconjug. Chem., 2003, 14(2), 412-419. (Pubitemid 36348665)
26. Griset, A.P.; Walpole, J.; Liu, R.; Gaffey, A.; Colson, Y.L.; Grinstaff, M.W. Expansile nanoparticles: Synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J. Am. Chem. Soc., 2009, 131(7), 2469-2471.
27. Wu, Y.; MacKay, J.A.; McDaniel, J.R.; Chilkoti, A.; Clark, R.L. Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules, 2009, 10(1), 19-24.
28. Grove, T.Z.; Osuji, C.O.; Forster, J.D.; Dufresne, E.R.; Regan, L. Stimuli-Responsive Smart Gels Realized via Modular Protein Design. J. Am. Chem. Soc., 2010, 132(40), 14024-14026.
29. Velasco, D.; Elvira, C.; San Román, J. New stimuli-responsive polymers derived from morpholine and pyrrolidine. J. Mater. Sci. Mater. Med., 2008, 19(4), 1453-1458.
30. Wijaya, A.; Schaffer, S.B.; Pallares, I.G.; Hamad-Schifferli, K. Selective release of multiple DNA oligonucleotides from gold nanorods. ACS nano, 2009, 3(1), 80-86.
31. Huang, X.; El-Sayed, I.H.; Qian, W.; El-Sayed, M.A. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: A potential cancer diagnostic marker. Nano Lett., 2007, 7(6), 1591-1597. (Pubitemid 47140430)
32. Chen, P.; Mwakwari, S.; Oyelere, A. Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnology, Science and Applications, 2008, 1, 45-66.
33. Fass, L. Imaging and cancer: A review. Molecular Oncology, 2008, 2(2), 115-152.
34. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nature Reviews Cancer, 2005, 5(3), 161-171. (Pubitemid 40314948)
35. Sumer, B.; Gao, J. Theranostic nanomedicine for cancer. Nanomedicine (Lond)., 2008, 3(2), 137-140. (Pubitemid 351611851)
36. Portney, N.; Ozkan, M. Nano-oncology: Drug delivery, imaging, and sensing. Analytical and Bioanalytical Chemistry, 2006, 384(3), 620-630. (Pubitemid 43237915)
37. Akinc, A.; Querbes, W.; De, S.; Qin, J.; Frank-Kamenetsky, M.; Jayaprakash, K.N.; Jayaraman, M.; Rajeev, K.G.; Cantley, W.L.; Dorkin, J.R.; Butler, J.S.; Qin, L.; Racie, T.; Sprague, A.; Fava, E.; Zeigerer, A.; Hope, M.J.; Zerial, M.; Sah, D.W.Y.; Fitzgerald, K.; Tracy, M.A.; Manoharan, M.; Koteliansky, V.; Fougerolles, A.d.; Maier, M.A. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther., 2010, 18(7), 1357-1364.
38. Elias, D.R.; Cheng, Z.; Tsourkas, A. An Intein-Mediated Site-Specific Click Conjugation Strategy for Improved Tumor Targeting of Nanoparticle Systems. Small, 2010, 6(21), 2460-2468.
39. Fakhari, A.; Baoum, A.; Siahaan, T.J.; Le, K.B.; Berkland, C. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. J. Pharm. Sci., 2011, 100(3), 1045-1056.
40. Sarfati, G.; Dvir, T.; Elkabets, M.; Apte, R.N.; Cohen, S. Targeting of polymeric nanoparticles to lung metastases by surfaceattachment of YIGSR peptide from laminin. Biomaterials, 2010, 32(1), 152-161.
41. Rezler, E.M.; Khan, D.R.; Lauer-Fields, J.; Cudic, M.; Baronas-Lowell, D.; Fields, G.B. Targeted drug delivery utilizing proteinlike molecular architecture. J. Am. Chem. Soc., 2007, 129(16), 4961-4972. (Pubitemid 46651374)
42. Eliaz, R.E.; Szoka, F.C. Liposome-encapsulated doxorubicin targeted to CD44: A strategy to kill CD44-overexpressing tumor cells. Cancer Res., 2001, 61(6), 2592-2601. (Pubitemid 32685844)
43. Faassen, A.E.; Schrager, J.A.; Klein, D.J.; Oegema, T.R.; Couchman, J.R.; McCarthy, J.B. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol., 1992, 116(2), 521-531.
44. Faassen, A.E.; Mooradian, D.L.; Tranquillo, R.T.; Dickinson, R.B.; Letourneau, P.C.; Oegema, T.R.; McCarthy, J.B. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J. Cell Sci., 1993, 105 (Pt 2), 501-511. (Pubitemid 23234168)
45. Park, J.W.; Kirpotin, D.B.; Hong, K.; Shalaby, R.; Shao, Y.; Nielsen, U.B.; Marks, J.D.; Papahadjopoulos, D.; Benz, C.C. Tumor targeting using anti-her2 immunoliposomes. J. Control Release, 2001, 74(1-3), 95-113. (Pubitemid 32727613)
46. Li, X.; Ding, L.; Xu, Y.; Wang, Y.; Ping, Q. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int. J. Pharm., 2009, 373(1-2), 116-123.
47. Cukierman, E.; Khan, D.R. The benefits and challenges associated with the use of drug delivery systems in cancer therapy. Biochem. Pharmacol., 2010, 80(5), 762-770.
48. Kim, Y.K.; Kwon, J.T.; Choi, J.Y.; Jiang, H.L.; Arote, R.; Jere, D.; Je, Y.H.; Cho, M.H.; Cho, C.S. Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus. Cancer Gene Ther., 2010, 17(11), 751-760.
49. Yap, T.A.; Carden, C.P.; Kaye, S.B. Beyond chemotherapy: Targeted therapies in ovarian cancer. Nat. Rev. Cancer, 2009, 9(3), 167-181.
50. Miyata, T.; Asami, N.; Uragami, T. A reversibly antigenresponsive hydrogel. Nature, 1999, 399(6738), 766-769.
51. Miyata, T.; Jige, M.; Nakaminami, T.; Uragami, T. Tumor markerresponsive behavior of gels prepared by biomolecular imprinting. PNAS, 2006, 103(5), 1190-1193. (Pubitemid 43191140)
52. Byrne, M.E.; Hilt, J.Z.; Peppas, N.A. Recognitive biomimetic networks with moiety imprinting for intelligent drug delivery. J. Biomed. Mater. Res. A., 2008, 84(1), 137-147. (Pubitemid 350244255)
53. Bayer, C.L.; Konuk, A.A.; Peppas, N.A. Development of a protein sensing device utilizing interactions between polyaniline and a polymer acid dopant. Biomed. Microdevices, 2010, 12(3), 435-442.
54. Byrne, M.E.; Park, K.; Peppas, N.A. Molecular imprinting within hydrogels. Adv. Drug Deliv. Rev., 2002, 54(1), 149-161. (Pubitemid 34075318)
55. Peppas, N.A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm., 2000, 50(1), 27-46. (Pubitemid 30326687)
56. Vartak, D.G.; Gemeinhart, R.A. Matrix metalloproteases: Underutilized targets for drug delivery. Journal of drug targeting, 2007, 15(1), 1-20.
57. Gobin, A.S.; West, J.L. Val-ala-pro-gly, an elastin-derived nonintegrin ligand: Smooth muscle cell adhesion and specificity. J. Biomed. Mater. Res. A., 2003, 67(1), 255-259. (Pubitemid 37517175)
58. Zisch, A.H.; Lutolf, M.P.; Ehrbar, M.; Raeber, G.P.; Rizzi, S.C.; Davies, N.; Schmökel, H.; Bezuidenhout, D.; Djonov, V.; Zilla, P.; Hubbell, J.A. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J., 2003, 17(15), 2260-2262. (Pubitemid 39561459)
59. Zisch, A.H.; Lutolf, M.P.; Hubbell, J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc. Pathol., 2003, 12(6), 295-310. (Pubitemid 37433840)
60. Aimetti, A.A.; Machen, A.J.; Anseth, K.S. Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzymeresponsive protein delivery. Biomaterials, 2009, 30(30), 6048-6054.
61. Glangchai, L.C.; Caldorera-Moore, M.; Shi, L.; Roy, K. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J. Control Release, 2008, 125(3), 263-272.
62. Tauro, J.R.; Lee, B.-S.; Lateef, S.S.; Gemeinhart, R.A. Matrix metalloprotease selective peptide substrates cleavage within hydrogel matrices for cancer chemotherapy activation. Peptides, 2008, 29(11), 1965-1973.
63. Baram, D.; Vaday, G.; Salamon, P.; Drucker, I.; Hershkoviz, R.; Mekori, Y. Human mast cells release metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-{alpha}. The Journal of Immunology, 2001, 167, 4008-4016. (Pubitemid 32910846)
64. Simpson, J.L.; Scott, R.J.; Boyle, M.J.; Gibson, P.G. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care Med., 2005, 172(5), 559-565. (Pubitemid 41232966)
65. Tauro, J.R.; Gemeinhart, R.A. Extracellular protease activation of chemotherapeutics from hydrogel matrices: A new paradigm for local chemotherapy. Molecular pharmaceutics, 2005, 2(5), 435-438. (Pubitemid 41503685)
66. Tokatlian, T.; Shrum, C.T.; Kadoya, W.M.; Segura, T. Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2-and 3-dimensions. Biomaterials, 2010, 31(31), 8072-8080.
67. Thornton, P.D.; Heise, A. Highly specific dual enzyme-mediated payload release from peptide-coated silica particles. J. Am. Chem. Soc., 2010, 132(6), 2024-2028.
68. Podual, K.; Doyle, F.J.; Peppas, N.A. Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an environment of changing pH. Biomaterials, 2000, 21(14), 1439-1450. (Pubitemid 30259288)
69. Podual, K.; Doyle, F.J.; Peppas, N.A. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J. Control Release, 2000, 67(1), 9-17. (Pubitemid 30201676)
70. Satav, S.S.; Bhat, S.; Thayumanavan, S. Feedback regulated drug delivery vehicles: Carbon dioxide responsive cationic hydrogels for antidote release. Biomacromolecules, 2010, 11(7), 1735-1740.
71. Solsona, I.A.; Smith, R.B.; Livingstone, C.; Davis, J. Metabolic mimics: Thiol responsive drug release. J. Colloid Interface Sci., 2006, 302(2), 698-701. (Pubitemid 44332392)
72. Balendiran, G.K.; Dabur, R.; Fraser, D. The role of glutathione in cancer. Cell Biochem. Funct., 2004, 22(6), 343-352. (Pubitemid 39518098)
73. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The Protein Data Bank. Nucleic Acids Res., 2000, 28(1), 235-242. (Pubitemid 30047768)
74. Chang, A.; Scheer, M.; Grote, A.; Schomburg, I.; Schomburg, D. BRENDA, AMENDA and FRENDA the enzyme information system: New content and tools in 2009. Nucleic Acids Res., 2009, 37(Database issue), D588-592.
75. Gasteiger, E.; Gattiker, A.; Hoogland, C.; Ivanyi, I.; Appel, R.D.; Bairoch, A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res., 2003, 31(13), 3784-3788. (Pubitemid 37442246)
76. Newburger, D.E.; Bulyk, M.L. UniPROBE: An online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res., 2009, 37(Database issue), D77-82.
77. Fong, W.-K.; Hanley, T.; Boyd, B.J. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J. Control Release, 2009, 135(3), 218-226.
78. Janib, S.M.; Moses, A.S.; MacKay, J.A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev., 2010, 62(11), 1052-1063.
79. Ho, Y.-P.; Leong, K.W. Quantum dot-based theranostics. Nanoscale, 2010, 2(1), 60-68.
80. Debbage, P.; Jaschke, W. Molecular imaging with nanoparticles: Giant roles for dwarf actors. Histochem. Cell Biol., 2008, 130(5), 845-875.
81. Del Vecchio, S.; Zannetti, A.; Fonti, R.; Pace, L.; Salvatore, M. Nuclear imaging in cancer theranostics. Q. J. Nucl. Med. Mol. Imaging, 2007, 51(2), 152-163. (Pubitemid 47064656)
82. Picard, F.J.; Bergeron, M.G. Rapid molecular theranostics in infectious diseases. Drug Discov. Today, 2002, 7(21), 1092-1101. (Pubitemid 35341650)
83. Gilham, I.; Rowland, T. Predictive medicine: Potential benefits from the integration of diagnostics and pharmaceuticals. Journal of Medical Marketing, 2001, 2, 18-22.
84. Parks, S.K.; Chiche, J.; Pouysségur, J. pH control mechanisms of tumor survival and growth. J. Cell Physiol., 2010.
85. Pavet, V.; Portal, M.M.; Moulin, J.C.; Herbrecht, R.; Gronemeyer, H. Towards novel paradigms for cancer therapy. Oncogene, 2011, 30, 1-20.
86. Shen, Y.; Tang, H.; Radosz, M.; Van Kirk, E.; Murdoch, W.J. pHresponsive nanoparticles for cancer drug delivery. Methods Mol. Biol., 2008, 437, 183-216.
87. Gao, Z.G.; Lee, D.H.; Kim, D.I.; Bae, Y.H. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. Journal of drug targeting, 2005, 13(7), 391-397. (Pubitemid 43084539)
88. Lee, E.S.; Shin, H.J.; Na, K.; Bae, Y.H. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control Release, 2003, 90(3), 363-374. (Pubitemid 36859967)
89. Ko, J.; Park, K.; Kim, Y.-S.; Kim, M.S.; Han, J.K.; Kim, K.; Park, R.-W.; Kim, I.-S.; Song, H.K.; Lee, D.S.; Kwon, I.C. Tumoral acidic extracellular pH targeting of pH-responsive MPEGpoly( beta-amino ester) block copolymer micelles for cancer therapy. J. Control Release, 2007, 123(2), 109-115. (Pubitemid 47562136)
90. Andresen, T.L.; Jensen, S.S.; Kaasgaard, T.; Jørgensen, K. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Current drug delivery, 2005, 2(4), 353-362. (Pubitemid 41277767)
91. Gertz, M.A. New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression. Leuk. Lymphoma, 2008, 49(12), 2240-2245.
92. Tauro, J.R.; Gemeinhart, R.A. Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug. Chem., 2005, 16(5), 1133-1139. (Pubitemid 41368115)
93. Kaasgaard, T.; Andresen, T.L.; Jensen, S.S.; Holte, R.O.; Jensen, L.T.; Jørgensen, K. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery. Chem. Phys. Lipids, 2009, 157(2), 94-103.
94. Pedersen, P.J.; Adolph, S.K.; Subramanian, A.K.; Arouri, A.; Andresen, T.L.; Mouritsen, O.G.; Madsen, R.; Madsen, M.W.; Peters, G.H.; Clausen, M.H. Liposomal formulation of retinoids designed for enzyme triggered release. J. Med. Chem., 2010, 53(9), 3782-3792.
95. Harris, T.J.; von Maltzahn, G.; Lord, M.E.; Park, J.-H.; Agrawal, A.; Min, D.-H.; Sailor, M.J.; Bhatia, S.N. Protease-triggered unveiling of bioactive nanoparticles. Small, 2008, 4(9), 1307-1312.
96. Hatakeyama, H.; Akita, H.; Kogure, K.; Oishi, M.; Nagasaki, Y.; Kihira, Y.; Ueno, M.; Kobayashi, H.; Kikuchi, H.; Harashima, H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther., 2007, 14(1), 68-77. (Pubitemid 44942867)
97. Moss, J.A.; Stokols, S.; Hixon, M.S.; Ashley, F.T.; Chang, J.Y.; Janda, K.D. Solid-phase synthesis and kinetic characterization of fluorogenic enzyme-degradable hydrogel cross-linkers. Biomacromolecules, 2006, 7(4), 1011-1016. (Pubitemid 43670785)
98. Moustoifa, E.-F.; Alouini, M.-A.; Salaün, A.; Berthelot, T.; Bartegi, A.; Albenque-Rubio, S.; Déléris, G. Novel cyclopeptides for the design of MMP directed delivery devices: A novel smart delivery paradigm. Pharm. Res., 2010, 27(8), 1713-1721.
99. Wang, J. In vivo glucose monitoring: Towards 'Sense and Act' feedback-loop individualized medical systems. Talanta, 2008, 75(3), 636-641. (Pubitemid 351484145)
100. Asai, D.; Tsuchiya, A.; Kang, J.-H.; Kawamura, K.; Oishi, J.; Mori, T.; Niidome, T.; Shoji, Y.; Nakashima, H.; Katayama, Y. Inflammatory cell-specific transgene expression system responding to Ikappa-B kinase beta activation. J. Gene Med., 2009, 11(7), 624-632.
101. Barnes, P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nature Reviews Immunology, 2008, 8(3), 183-192. (Pubitemid 351323287)
102. Suzuki, Y.; Tanihara, M.; Nishimura, Y.; Suzuki, K.; Kakimaru, Y.; Shimizu, Y. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J. Biomed. Mater. Res., 1998, 42(1), 112-116. (Pubitemid 28413003)
103. Neut, D.; Kluin, O.S.; Crielaard, B.J.; van der Mei, H.C.; Busscher, H.J.; Grijpma, D.W. A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthop., 2009, 80(5), 514-519.
104. Asai, D.; Kuramoto, M.; Shoji, Y.; Kang, J.-H.; Kodama, K.B.; Kawamura, K.; Mori, T.; Miyoshi, H.; Niidome, T.; Nakashima, H.; Katayama, Y. Specific transgene expression in HIV-infected cells using protease-cleavable transcription regulator. J. Control Release, 2010, 141(1), 52-61.